Evidence map›Paper›PMID 34086070›Full record

ArticleDer Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft2021

Impact of the SARS-CoV-2 pandemic on ophthalmic care in Germany.

Lars-Olof Hattenbach, Peter Heinz, Nicolas Feltgen, Hans Hoerauf, Thomas Kohnen, Siegfried Priglinger, Werner Bachmann, Johannes Rieks, Nicole Eter, Thomas Reinhard

Abstract read
In one paragraph

Article in Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Lars-Olof HattenbachCommission for Cross-Sectoral Ophthalmology of the DOG (German Ophthalmological Society e. V.) and BVA (Professional Association of German Ophthalmologists), Munich/Düsseldorf, Germany. hattenbach.LO@klilu.de.
Peter HeinzCommission for Cross-Sectoral Ophthalmology of the DOG (German Ophthalmological Society e. V.) and BVA (Professional Association of German Ophthalmologists), Munich/Düsseldorf, Germany.
Nicolas FeltgenEye Clinic, University Hospital Göttingen, Göttingen, Germany.
Hans HoeraufCommission for Cross-Sectoral Ophthalmology of the DOG (German Ophthalmological Society e. V.) and BVA (Professional Association of German Ophthalmologists), Munich/Düsseldorf, Germany.
Thomas KohnenCommission for Cross-Sectoral Ophthalmology of the DOG (German Ophthalmological Society e. V.) and BVA (Professional Association of German Ophthalmologists), Munich/Düsseldorf, Germany.
Siegfried PriglingerCommission for Cross-Sectoral Ophthalmology of the DOG (German Ophthalmological Society e. V.) and BVA (Professional Association of German Ophthalmologists), Munich/Düsseldorf, Germany.
Werner BachmannCommission for Cross-Sectoral Ophthalmology of the DOG (German Ophthalmological Society e. V.) and BVA (Professional Association of German Ophthalmologists), Munich/Düsseldorf, Germany.
Johannes RieksCommission for Cross-Sectoral Ophthalmology of the DOG (German Ophthalmological Society e. V.) and BVA (Professional Association of German Ophthalmologists), Munich/Düsseldorf, Germany.
Nicole EterUniversity Eye Hospital Münster, Münster, Germany.
Thomas ReinhardCommission for Cross-Sectoral Ophthalmology of the DOG (German Ophthalmological Society e. V.) and BVA (Professional Association of German Ophthalmologists), Munich/Düsseldorf, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSurvey by the commission for cross-sectoral ophthalmology, as a joint commission of the German Ophthalmological Society (DOG) and the Professional Association of German Ophthalmologists (BVA) on the effects of the SARS-CoV‑2 pandemic on ophthalmological patient care in Germany.

methodsOnline-based survey.

resultsA total of 1190 questionnaires were (partly) answered. With respect to outpatient care and consultations from 15 March to 15 April 2020, a total of 69 (5.8%) participants indicated unlimited, 756 (63.5%) reduced and 330 (27.7%) emergency care only, independent of the type of institution. Outpatient surgery was restricted to emergency surgery in 68% of clinics, 42.0% of inpatient wards, 45.0% of surgical medical care centers and group practices and 33.0% of private practices. Inpatient procedures were limited to emergency care in 75.0% of inpatient wards and in 71.0% of clinics. With the exception of endophthalmitis (+8.2%), the number of urgent indications and emergencies declined: retinal detachment (-34.8%), perforating eyeball injuries (-7.3%), acute glaucoma (-17.8%), central retinal artery occlusion and anterior ischemic optic neuropathy (-31.0%), others (-30.9%), penetrating keratoplasty and amniotic membrane transplantation (-59.1%). Institutional or professional policy requirements (76.0%) and appointment cancellation by patients (84.0%) were the most common reasons for limitations in ophthalmic patient care.

conclusionThe initial phase of the pandemic was characterized by a massive reduction in non-urgent conservative and surgical treatment that affected all areas of ophthalmology. Due to intensive care capacities required for COVID-19 patients, inpatient treatment was largely restricted to emergencies. Treatment of ophthalmological patients, including ocular emergencies and urgent treatment, was maintained across all sectors with a (considerable) decrease in the number of cases even in these groups.

Indexed as

COVID-19OphthalmologistsGermanyHumansPandemicsSARS-CoV-2COVID-19Elective surgeryInpatient careOphthalmological emergenciesOutpatient care

Identifiers

PMID34086070
PMCPMC8176275

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.